Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XSTEM-VLU in Difficult-to-heal Venous Leg Ulcers
NCT05549609Phase 2Completed
- Sponsor
- Xintela AB
- Start
- Oct 2022
- Primary completion
- Feb 2026
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of XSTEM-VLU in venous leg ulcer (VLU), sponsored by Xintela AB. Started Oct 2022; status: completed.
02
Drugs
XSTEM-VLU
03
Conditions
venous leg ulcer (VLU)
Beyond the preview
Go deeper on NCT05549609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05549609.